The clinical management of tumour lysis syndrome in haematological malignancies.
about
Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)A review in the treatment of oncologic emergencies.Tumor lysis syndrome: new challenges and recent advances.Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the LiteratureControlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndromeTumor lysis syndrome and primary hepatic malignancy: case presentation and review of the literatureRasburicase for the treatment of tumor lysis in hematological malignancies.Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.Spontaneous tumor lysis syndrome in a patient with cholangiocarcinoma.An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.A Case of Spontaneous Tumor Lysis Syndrome in a Patient with Ovarian Cancer.Spontaneous Tumor Lysis Syndrome in Small-Cell Lung Cancer: A Rare Complication.Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcomaSpontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung Metastases.Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.
P2860
Q26745670-538B3100-060E-479E-818F-69CC2600C362Q30252082-3DFEB8A6-78F1-4477-ACE4-7395B04460D7Q33595615-1118502D-4FFA-434D-BD35-FEDC7F0CCBFAQ33852544-779856A8-D301-4475-8147-4382A14A752CQ34141630-AA8CE417-7F72-4924-8836-D0FB6AA16524Q35136271-AC8DF78B-5FAE-4017-832B-ED213C155AFDQ37978342-80CC91C7-E840-4B96-B8F3-16AF03ADA486Q38000087-641475E3-7BC2-4777-86DA-0A1AD0D78845Q38017664-D6E8E767-662F-4642-82B0-A7618C745B63Q38656591-FDBF4DBD-9DCD-4825-A045-36BD63023610Q38965174-CF21F272-C1E3-4E01-B01D-71C222765526Q39893104-452537BD-313D-4F87-A73C-E9FBE7052BD5Q41526241-080ECFF9-DD59-46D8-9190-45EF50DC2EAAQ42075256-CBD80AD3-87F2-4037-979F-74240042B779Q42181725-9C24FFEA-FC73-4DFB-A313-4DFA01CD99ACQ47140630-8CD52DE7-8A64-46AE-B851-829B0C0C7698Q54432465-82141622-42BD-48A7-99C6-8B7FDE19BEE9
P2860
The clinical management of tumour lysis syndrome in haematological malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical management of tumour lysis syndrome in haematological malignancies.
@en
The clinical management of tumour lysis syndrome in haematological malignancies.
@nl
type
label
The clinical management of tumour lysis syndrome in haematological malignancies.
@en
The clinical management of tumour lysis syndrome in haematological malignancies.
@nl
prefLabel
The clinical management of tumour lysis syndrome in haematological malignancies.
@en
The clinical management of tumour lysis syndrome in haematological malignancies.
@nl
P2860
P1476
The clinical management of tumour lysis syndrome in haematological malignancies.
@en
P2093
Andrew Will
Eleni Tholouli
P2860
P356
10.1111/J.1365-2141.2011.08697.X
P407
P577
2011-05-09T00:00:00Z